T cell-oriented strategies for controlling the COVID-19 pandemic

[1]  F. Rey,et al.  Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization , 2021, Nature.

[2]  R. Scheuermann,et al.  Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals , 2021, Cell Reports Medicine.

[3]  Mark M. Davis,et al.  CD8+ T cells specific for conserved coronavirus epitopes correlate with milder disease in patients with COVID-19 , 2021, Science Immunology.

[4]  E. Shin,et al.  SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells , 2021, Nature Communications.

[5]  E. Wherry,et al.  CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer , 2021, Nature Medicine.

[6]  L. Rénia,et al.  Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study , 2021, The Lancet Microbe.

[7]  Jincun Zhao,et al.  Mapping and role of T cell response in SARS-CoV-2–infected mice , 2021, The Journal of experimental medicine.

[8]  D. Lauffenburger,et al.  Correlates of Protection Against SARS-CoV-2 in Rhesus Macaques , 2020, Nature.

[9]  J. Greenbaum,et al.  Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity , 2020, Cell.

[10]  Martin Linster,et al.  SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls , 2020, Nature.

[11]  Maja O’Connor.  LONGITUDINAL STUDY , 2013 .